Ketamine clinic marketing
More consults and treatment starts, from ketamine clinic marketing
Medicare’s 2026 national rate for one Spravato session reaches $1,356.08, yet ads show on 1.1% of ketamine search volume, so we count starts from search, maps and AI answers.
Request the ketamine patient question sheetThe economics
What a ketamine treatment start pays, and the price of winning one
Three sourced figures on each side. Medicare publishes what it allows for a Spravato session; IV infusion prices are each clinic’s own and vary widely.
What one treatment start is worth
- Medicare, one Spravato session above 56 mgHCPCS G2083, 2026, national, non-facility, before geographic adjustment: 40.60 RVUs × $33.4009, esketamine and observation included.
- $1,356.08
- Medicare, one Spravato session of 56 mg or lessHCPCS G2082 on the same basis: 28.52 RVUs × $33.4009. The label’s induction phase is two sessions a week for four weeks.
- $952.59
- Published cash price, one IV ketamine infusionThe range among the 7 of 13 Maryland infusion advertisers that listed a price in March 2023. One state and one month, not a national average.
- $360 to $2,500
What one costs to win
- Cost per click, “ketamine therapy”110,000 searches a month. Of 332 patient searches with 100 or more a month, 262 show no click price; the 70 priced have a median of $4.81.
- $7.18
- Patient search volume where ads appearedAcross 10,503 ketamine therapy and clinic searches, 349,920 a month. Top-of-page ads appeared on less than 0.1%.
- 1.1%
- LegitScript, telehealth or addiction advertisersYear one per website: $975 to apply plus $2,150 a year. Google asks for it only from telemedicine providers and addiction services.
- $3,125
With ads on so little of the search volume, a clinic wins treatment starts through organic results, the map pack and AI answers. Each start leads to repeat sessions, so the work is judged on starts counted in the clinic’s own schedule.
Who we work with
Four kinds of ketamine practice, each judged on its own number
The treatment, who pays and who signs differ by practice. The right-hand column opens the service page that comes first for each.
| Practice | What decides the return | Read first |
|---|---|---|
| Independent IV ketamine infusion clinics | Cash-pay patients within driving distance who finish a consult and an induction series. A page about depression describes an off-label use. | Local SEO |
| Psychiatry practices offering Spravato | Insurance-billed patients who qualify, with benefits verified before the first session in a REMS-certified office. | AI receptionist |
| Ketamine-assisted psychotherapy practices | Clients ready for preparation and integration sessions. Oral and sublingual ketamine are compounded products FDA has not approved for any use. | Content marketing |
| Multi-site ketamine and interventional psychiatry groups | Treatment starts by office and service line, each office in its own map pack, and state rules such as Georgia’s license from July 1, 2027. | SEO services |
IV ketamine, Spravato and KAP each carry their own claims rules, so a group that offers all three needs a separate page set for each.
The rules
The FDA, FTC, DEA and ad rules behind IV ketamine and Spravato pages
Eight rules on what an infusion clinic or Spravato practice may claim, track and advertise, each as strong as its source.
Ketamine is not FDA-approved for any psychiatric disorder, so a page on IV ketamine for depression describes an off-label use.
FDA approves ketamine as an IV or IM injection for anesthesia. Its October 2023 safety alert adds that it knows of no evidence that compounded ketamine is safer, more effective or faster than approved medications.
A response rate, “proven” or “safe and effective” needs trial evidence on file before the treatment page goes live.
Before a health-benefit claim runs, the FTC expects competent and reliable scientific evidence, which it says generally means randomized controlled human trials. A rate is quoted only with its study, population and endpoint named, such as the ELEKT-D trial’s 403 patients referred for ECT.
Spravato is given only in REMS-certified settings, with at least two hours of monitoring, and the spray never goes home.
Spravato is approved for treatment-resistant depression and for depressive symptoms with acute suicidal ideation, through its REMS only. Its pages cannot borrow IV ketamine’s claims, and IV ketamine pages cannot borrow Spravato’s approval.
Consult, screening, booking and portal pages carry no ad or analytics tags.
A screening answer passed to an ad platform tells it about a mental health condition. HHS treats a tracking vendor on a booking page as a business associate needing an agreement, and a federal court in 2024 set aside only HHS’s view of public pages.
Bidding on keywords that contain a prescription drug term needs Google’s approval, and Google’s monitored list names Ketalar.
In the US, ads and landing pages may name prescription drugs. LegitScript and Google certification apply to telemedicine providers, such as a clinic that prescribes after a video visit, and to addiction services, not to every ketamine ad.
Ketamine for alcohol or opioid use disorder needs LegitScript addiction services certification before Google ads run.
Google requires its own certification as well, and not every addiction service qualifies. A clinic that holds itself out as treating substance use disorder and is federally assisted, by Medicare participation or a DEA registration used for that treatment, becomes a Part 2 program.
A DEA-registered practitioner may prescribe ketamine by telemedicine, with no in-person evaluation, through December 31, 2026.
Ketamine is a Schedule III drug. The DEA’s fourth temporary extension runs to that date, and as of November 9, 2026 no further extension or final special-registration rule had been published, so a telehealth page carries the date.
Georgia requires clinics giving IV ketamine to hold a medical board license from July 1, 2027.
HB 717 (Act 634) was signed May 12, 2026. The board’s rules, due by December 31, 2026, must cover truth in advertising about the credentials, education and training of whoever gives the treatment, so clinician pages state them exactly.
Services for ketamine clinics
Services that move consults and starts, from search to maintenance
Each entry opens the national service page, with a line on what changes for IV ketamine and Spravato. The groups follow a patient from the first search to a maintenance booking.
Get found where patients research
- SEO servicesTreatment, condition and cost pages for searches such as “ketamine therapy”, at 110,000 a month
- Local SEOEach office in its own map pack, which shows on 42.0% of “ketamine clinic” search volume, for consults within driving distance
- AI search optimizationA dated record of which clinics AI answers name for a fixed set of patient questions
- Google Business ProfileA profile per office, listing IV ketamine and Spravato only where each is given
Turn questions into consults
- Web designSeparate IV ketamine and Spravato pages, off-label status stated and clinicians named
- Content marketingAnswers on cost, coverage and candidacy, each claim tied to a named study and read by the medical director
- Conversion rate optimizationMore consults from visits already earned, tested without tags on the screening step
- Landing page designOne page per treatment, with one action and no third-party tags on its form
Answer, remind and follow up
- AI receptionistConsult calls answered after hours, with any mention of suicide handed to a person
- CRM implementationA pipeline from the first call to the first infusion or Spravato session, so cost per treatment start comes from the chart
- Marketing automationConsult reminders and maintenance follow-up, through vendors an agreement covers
- SMS automationSession reminders and ride-home confirmations inside the FCC limits on health messages
Keep claims and reviews sound
- Reputation managementReview requests sent once the patient has recovered from the dose, and replies that never confirm a reviewer was a patient
- SEO auditA fixed-scope check of treatment claims, office profiles, form tags and AI answers
- ADA website complianceWCAG 2.2 AA on consult and booking forms, for patients using assistive technology
The rest of the suite, on national pages
- AI and automationAI receptionists, chat and automations with a defined job and a person to hand to.
- Apps and softwareiPhone, Android and web apps, scoped to a fixed first version and built in your accounts.
- BrandingStrategy, identity and materials, built for the buyer you want to win.
- Digital marketingAds, follow-up and tracking, judged by the cost of a booked client.
- SEO servicesGoogle and AI answers, worked as one job and reported in one place.
- Web designSites built to book clients, fast on a phone, and in your name.
The playbook
A clinic playbook, measured in treatment starts
Each stage moves a number the clinic already keeps in its schedule, phone log or charts. The documents are worked samples for Sample Live Oak Ketamine Center, a fictional two-office clinic in Savannah, Georgia.
Treatment page claims, baseline
| Check on 6 treatment pages | At baseline | Change |
|---|---|---|
| States which uses are off-label | 0 pages | Add to each page |
| Calls ketamine FDA-approved | 2 pages | Remove |
| Response rate with no study named | 5 pages | Name the study or cut |
| Calls ketamine nonaddictive | 1 page | Remove |
A sample month
Sample Live Oak Ketamine Center, consults held by source
Consults held in an average month from June to August 2026, before the work began, and the treatment starts that followed. The clinic is fictional, with offices in Midtown Savannah and Pooler.
- 01
Search brought 62 consults with no ads running
Organic results and the map pack brought 62 of the 126, almost half, while Google Ads sat paused after 9 ads were disapproved. Clinician referrals, at 30, led the sources outside search.
- 02
Three smaller sources made up 17
Directories brought 8, AI answers 5 and other sources 4, each recorded at intake. Before the work, the clinic was named in answers to 2 of 12 fixed patient questions across 4 AI engines.
- 03
Under half of the consults held became starts
60 of 126, or 47.6%, became treatment starts: 38 IV induction series and 22 Spravato courses. Screening turns some people away by design, so the medical director reads this rate with us.
Specialist or generalist
Where a ketamine-fluent agency works differently
Any agency can build a clinic site. These rows are where the work changes once a page describes a controlled substance used off-label; put each one to any agency you are weighing.
| General agencyBuilt around channels | Ketamine-fluent agencyBuilt around FDA status and patient data | |
|---|---|---|
| Treatment claims | Claims drawn from the clinic’s brief and other clinics’ pages | Off-label status stated, and a response rate only with its study named |
| Spravato and IV pages | One ketamine page covering each treatment the clinic gives | Separate pages, so Spravato’s approval never describes IV ketamine |
| Screening forms | Conversion tags placed on form submissions | No ad or analytics tags on consult, screening or booking pages |
| Ad eligibility | Campaigns planned from keyword volume and budget | Which services need Google approval or LegitScript, set out before any ad spend |
| Crisis calls | Call answering scripted for booking | A written protocol that hands any mention of suicide to a person |
| What is reported | Clicks, form fills and cost per lead | Consults held, treatment starts and inductions completed, by source |
A clinic that gives Spravato, prescribes by telehealth or treats addiction needs all six rows answered in writing. An infusion clinic that only wants new office photos and a refreshed profile can work with either.
Questions
Clinic owners’ questions, from FDA status to crisis calls
Short answers, each naming the rule or the study behind it.
Ketamine clinic statistics
Ketamine figures, from patients to advertising claims
Four of the 29 sourced figures. The statistics page links each one to the document it came from.
| Figure | What it measures |
|---|---|
| 2.8 million | US adults with treatment-resistant depression, claims-based estimate |
| 58.8% | Maryland ketamine advertisers not disclosing off-label use, 2023 |
| 36.5% | New York-area clinics prescribing ketamine for at-home use, 2025 |
| 60.8% | Ketamine search volume showing a Google AI Overview, 2026 |
Start here
See which clinics AI answers name for ketamine in your metro
Tell us your metro and the treatments you give. We put the questions patients ask, such as what IV ketamine costs in Denver, to ChatGPT and Google’s AI, and send a dated sheet of the clinics named.